Related Experiment Video
Updated: Mar 12, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
LMP1 signaling pathway activates IRF4 in latent EBV infection and a positive circuit between PI3K and Src is required
1Division of Infectious Diseases, Department of Internal Medicine, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
Insights
Epstein-Barr virus protein LMP1 activates Interferon Regulatory Factor 4 (IRF4) via c-Src kinase signaling. This pathway, involving PI3K, is crucial for IRF4 activity in virus-transformed cells and may offer therapeutic targets.
Area of Science:
- Molecular Biology
- Virology
- Immunology
- Oncology
Background:
- Interferon (IFN) regulatory factors (IRFs) are critical in immune responses and cancer development.
- IRF4 activation by c-Src tyrosine phosphorylation is known in virus-transformed cells.
- The specific signaling pathway leading to c-Src activation of IRF4 remains unclear.
Purpose of the Study:
- To elucidate the intracellular signaling pathway responsible for Epstein-Barr virus (EBV) LMP1-mediated IRF4 activation.
- To investigate the role of c-Src and phosphatidylinositol 3 kinase (PI3K) in this signaling cascade.
- To identify potential therapeutic targets within the IRF4 regulatory network for hematological malignancies.
Main Methods:
- Investigated the interaction between EBV latent membrane protein 1 (LMP1) and c-Src.
- Utilized short hairpin RNAs (shRNAs) to deplete the PI3K subunit P85 and assess its role.
- Employed the PI3K-specific inhibitor LY294002 to evaluate kinase activity and signaling pathways.
Main Results:
- EBV LMP1 directly promotes IRF4 phosphorylation and enhances its transcriptional activity.
- c-Src mediates LMP1-induced IRF4 activation, with LMP1 physically interacting with c-Src via the PI3K P85 subunit.
- Src acts upstream of PI3K in activating both IRF4 and Akt; PI3K inhibition impairs Src activity.
Conclusions:
- LMP1 signaling is the primary driver of IRF4 activation in EBV-transformed cells.
- The identified signaling pathway involving LMP1, c-Src, PI3K, and IRF4 provides a deeper understanding of viral oncogenesis.
- This IRF4 regulatory network represents a promising therapeutic target for treating specific hematological cancers.
Abstract:
Interferon (IFN) regulatory factors (IRFs) have crucial roles in immune regulation and oncogenesis. We have recently shown that IRF4 is activated through c-Src-mediated tyrosine phosphorylation in virus-transformed cells. However, the intracellular signaling pathway triggering Src activation of IRF4 remains unknown. In this study, we provide evidence that Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) promotes IRF4 phosphorylation and markedly stimulates IRF4 transcriptional activity, and that Src mediates LMP1 activation of IRF4. As to more precise mechanism, we show that LMP1 physically interacts with c-Src, and the phosphatidylinositol 3 kinase (PI3K) subunit P85 mediates their interaction. Depletion of P85 by P85-specific short hairpin RNAs disrupts their interaction and diminishes IRF4 phosphorylation in EBV-transformed cells. Furthermore, we show that Src is upstream of PI3K for activation of both IRF4 and Akt. In turn, inhibition of PI3K kinase activity by the PI3K-speicfic inhibitor LY294002 impairs Src activity. Our results show that LMP1 signaling is responsible for IRF4 activation, and further characterize the IRF4 regulatory network that is a promising therapeutic target for specific hematological malignancies.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
IP3/DAG Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
MAPK Signaling Cascades

